We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » McKesson Draws FDA’s First DSCSA-Related Warning Letter
McKesson Draws FDA’s First DSCSA-Related Warning Letter
The FDA issued its first warning letter under the Drug Supply Chain Security Act (DSCSA), hitting McKesson for violating verification requirements and allegedly shipping illegitimate product.